The Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology and Oncology 2022

Elevate Your Hematology and Oncology CME

The Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology and Oncology is a case-based online CME course focused on improving overall knowledge and clinical competency. Prep for your board exam and stay current on basic principles, changing guidelines and therapeutic strategies. Practice improvement areas featured in the continuing medical education program include:

• Acquired/Congenital Bone Marrow Failure
• Thalassemia/Hemoglobinopathies
• Transfusion Medicine
• New Therapies (Pharmacology)
• Infections of the Immunocompromised
• Hematologic Malignancies (Acute/Chronic Leukemias; Myeloma/Lymphomas)
• Thoracic Oncology (Head/Neck/Lung/Thyroid)
• and many more…

Topics/Speakers

• Molecular Genetics of Cancer – Nikhil Wagle, MD
• Advances in Cancer Drug Development Part I – Chemotherapy and Targeted Agents – Geoffrey I. Shapiro, MD, PhD
• Advances in Cancer Drug Development Part II – Modulation of the Tumor Microenvironment – Geoffrey I. Shapiro, MD, PhD
• Infections in Cancer Patients – Lindsey Baden, MD
• Symptom Management in Patients with Cancer – Andrew J. Lawton, MD
• Communication: The Key to Excellence in End-of-Life Care – Rachelle E. Bernacki, MD
• Biology of Hematopoietic Stem Cell Transplantation – Robert J. Soiffer, MD
• Biology of Acute Leukemia and Myelodysplastic Syndromes – Benjamin L. Ebert, MD, PhD
• Acute Leukemias – Daniel J. DeAngelo, MD, PhD
• Myelodysplastic Syndrome – Eric S. Winer, MD
• Chronic Myelogenous Leukemia – Marlise R. Luskin, MD
• Myeloproliferative Syndromes – Ann M. Mullally, MD
• Multiple Myeloma – Kenneth C. Anderson, MD
• Waldenstrom Macroglobulemia and Amyloidosis – Jorge Castillo, MD
• Low Grade Lymphomas – Caron A. Jacobson, MD
• Aggressive Non-Hodgkin Lymphoma – Eric Jacobsen, MD
• Hodgkin’s Lymphoma – Reid W. Merryman, MD
• Diagnosis and Treatment of CLL and Related B Cell Malignancies – Matthew S. Davids, MD
• Head and Neck Cancer – Robert I. Haddad, MD
• Natural History, Screening, and Small Cell Lung Cancer – Bruce E. Johnson, MD
• Non Small Cell Lung Cancer – Part 1 – Mark Awad, MD, PhD
• Non Small Cell Lung Cancer – Part 2 – Mark Awad, MD, PhD
• Mesothelioma and Thymoma – David M. Jackman, MD
• Carcinoid and Neuroendocrine Tumors – Jennifer Ang Chan, MD
• Novel Approaches for the Management of Esophageal and Gastric Cancers – Peter C. Enzinger, MD
• Pancreatic Cancer – Brian M. Wolpin, MD
• Hepatobiliary Cancer – James M. Cleary, MD, PhD
• Anal Cancer & Colorectal Cancers Part 1 – Robert J. Mayer, MD
• Colorectal Cancers Part 2 – Robert J. Mayer, MD
• Gastrointestinal Cancer: Genetic Syndromes – Matthew Yurgelun, MD
• Testicular Cancer – Mark M. Pomerantz, MD
• Renal and Bladder Cancer – Guru P. Sonpavde, MBBS
• Prostate Cancer Part I: Overview and Management of Localized Disease – Atish Choudhury, MD, PhD
• Prostate Cancer Part II: Management of Disseminated Prostate Cancer – Atish Choudhury, MD, PhD
• Melanoma – F. Stephen Hodi, MD
• Sarcomas and Gastrointestinal Stromal Tumors (GIST) – Suzanne George, MD
• Molecular Advances and Emerging Treatment Strategies in Ovarian Cancer – Ursula A. Matulonis, MD
• Cervical and Endometrial Cancer – Panagiotis A. Konstantinopoulos, MD, PhD
• Neuro-oncology – David A. Reardon, MD
• Breast Cancer – Risk Factors, Genetics, Screening, and Prevention – Judy E. Garber, MD, MPH
• Multimodality Therapy for Early Stage Breast Cancer: Part 1 – Surgery and Radiation – Harold J. Burstein, MD, PhD
• Multimodality Therapy for Early Stage Breast Cancer: Part 2 – Systemic Therapy – Harold J. Burstein, MD, PhD
• Management of Metastatic Breast Cancer – Adrienne G. Waks, MD
• Breast Cancer Survivorship – Ann H. Partridge, MD, MPH
• Hematopoiesis and Cytokines – David T. Scadden, MD
• Acquired Bone Marrow Failure – Julie-Aurore Losman, MD, PhD
• Congenital Bone Marrow Failure – Akiko Shimamura, MD, PhD
• Hemophagocytic Syndromes and Related Immunodeficiencies – Barbara A. Degar, MD
• Anemia – An Overview – Robert Stern, MD
• Iron Deficiency and Iron Overload – Mark D. Fleming, MD, Dphil
• Immune Hemolytic Anemia – Richard M. Kaufman, MD
• Non-immune Hemolytic Anemia – David E. Golan, PhD, MD
• Sickle Cell Disease – Maureen M. Achebe, MD, MPH
• Thalassemia and Other Hemoglobinopathies – Matthew M. Heeney, MD
• Disorders of Neutrophils – Nancy Berliner, MD
• Acquired Thrombocytopenias – Elisabeth M. Battinelli, MD, PhD
• Hemophilia – Aric D. Parnes, MD
• Von Willebrand Disease and Congenital Platelet Disorders – Nathan T. Connell, MD, MPH
• Congenital and Acquired Thrombophilia – Kenneth A. Bauer, MD
• Use of Direct Oral Anticoagulants in Clinical Practice – Jean M. Connors, MD
• Transfusion Medicine for the Clinician – Walter H. Dzik, MD